Lymphoproliferative Disorders
📧 Sign up to get email alerts when something new happens for Lymphoproliferative Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-12-05Clinical Trial Update: Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT [Phase 1]
A Phase 1 trial evaluating a preemptive infusion of donor lymphocytes depleted of TCR+ T cells and CD19+ B cells after autologous stem cell …
-
CLINICAL_TRIALS withdrawal · 2023-04-21Clinical Trial Update: A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma [Phase 3]
A Phase 3 trial combining Zilovertamab with Ibrutinib for relapsed or refractory mantle cell lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-11-13Clinical Trial Update: Phase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AML [Phase 1]
Zenith Epigenetics has withdrawn its Phase 1 trial of ZEN003365 for relapsed/refractory lymphoproliferative disorders and acute myeloid leuk…
-
CLINICAL_TRIALS withdrawal · 2013-04-15Clinical Trial Update: Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders [Phase 1]
A Phase 1 study evaluating phenethyl isothiocyanate for leukemia and other lymphoproliferative disorders was withdrawn. The sponsor was MD A…